Over 400 North Carolina Auctions End Today - Bid Now
Over 250 Total Lots Up For Auction at Four Locations - Over 200 New York Auctions End Tomorrow 02/02 - Bid Now, UT 02/03, TX 02/10, Ontario 02/14

Four ways artificial intelligence is revolutionizing health care

March 01, 2017
Health IT
From the March 2017 issue of HealthCare Business News magazine

3: Population health

With the health care industry moving toward outcomes-based reimbursement, population health management initiatives are no longer optional. Machine learning applications enable hospitals to support data-driven population health management initiatives by enabling predictive patient population risk assessment, care gaps identification and prescriptive patient intervention guidance.

Reveal 35C: spectral bedside imaging, no extra dose, now available in the EU

KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at sales@kaimaging.com to book a free demo.


Hospitals rely on patient risk scores to help physicians achieve the best possible outcomes while optimizing the use of scarce resources. With machine intelligence, clinicians can assess patient risk more effectively than they could with a patient questionnaire assessing readmission risks, which can be highly subject to interpretation. Machine intelligence approaches can incorporate current risk scores alongside a wide variety of patient clinical, financial and socioeconomic data to assess patient subpopulation risk for future disease states, cost, utilization and other types of risk from the patients’ and health system’s perspective.

By using machine learning to support population health management initiatives, hospitals and health systems benefit from being able to better understand quality indicators and identify ways to improve care outcomes while managing financial risk against emerging value-based reimbursement schemes. Mt. Sinai recently used machine intelligence to analyze clinical and genomic data from a population of type 2 diabetes (T2D) patients. The unbiased machine intelligence analysis identified heretofore unknown three distinct subtypes of T2D patients with distinct clinical and genomic characteristics. This advanced population stratification capability will inform the design of precision treatment regimens.


Next: Patient monitoring and telehealth


You Must Be Logged In To Post A Comment